Diacylglycerol kinase α inhibition cooperates with PD-1-targeted therapies to restore the T cell activation program.
Saved in:
| Title: | Diacylglycerol kinase α inhibition cooperates with PD-1-targeted therapies to restore the T cell activation program. |
|---|---|
| Authors: | Arranz-Nicolás J; Immunology and Oncology, Centro Nacional de Biotecnología-CSIC, Madrid, Spain. jarranz@cnb.csic.es., Martin-Salgado M; Immunology and Oncology, Centro Nacional de Biotecnología-CSIC, Madrid, Spain., Adán-Barrientos I; Immunology and Oncology, Centro Nacional de Biotecnología-CSIC, Madrid, Spain., Liébana R; Immunology and Oncology, Centro Nacional de Biotecnología-CSIC, Madrid, Spain., Del Carmen Moreno-Ortíz M; Immunology and Oncology, Centro Nacional de Biotecnología-CSIC, Madrid, Spain., Leitner J; Center for Pathophysiology, Institute of Immunology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria., Steinberger P; Center for Pathophysiology, Institute of Immunology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria., Ávila-Flores A; Immunology and Oncology, Centro Nacional de Biotecnología-CSIC, Madrid, Spain., Merida I; Immunology and Oncology, Centro Nacional de Biotecnología-CSIC, Madrid, Spain. imerida@cnb.csic.es. |
| Source: | Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2021 Nov; Vol. 70 (11), pp. 3277-3289. Date of Electronic Publication: 2021 Apr 10. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 33837851 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Diacylglycerol kinase α inhibition cooperates with PD-1-targeted therapies to restore the T cell activation program. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Arranz-Nicolás+J%22">Arranz-Nicolás J</searchLink>; Immunology and Oncology, Centro Nacional de Biotecnología-CSIC, Madrid, Spain. jarranz@cnb.csic.es.<br /><searchLink fieldCode="AU" term="%22Martin-Salgado+M%22">Martin-Salgado M</searchLink>; Immunology and Oncology, Centro Nacional de Biotecnología-CSIC, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Adán-Barrientos+I%22">Adán-Barrientos I</searchLink>; Immunology and Oncology, Centro Nacional de Biotecnología-CSIC, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Liébana+R%22">Liébana R</searchLink>; Immunology and Oncology, Centro Nacional de Biotecnología-CSIC, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Del+Carmen+Moreno-Ortíz+M%22">Del Carmen Moreno-Ortíz M</searchLink>; Immunology and Oncology, Centro Nacional de Biotecnología-CSIC, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Leitner+J%22">Leitner J</searchLink>; Center for Pathophysiology, Institute of Immunology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Steinberger+P%22">Steinberger P</searchLink>; Center for Pathophysiology, Institute of Immunology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Ávila-Flores+A%22">Ávila-Flores A</searchLink>; Immunology and Oncology, Centro Nacional de Biotecnología-CSIC, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Merida+I%22">Merida I</searchLink>; Immunology and Oncology, Centro Nacional de Biotecnología-CSIC, Madrid, Spain. imerida@cnb.csic.es. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228605732%22">Cancer immunology, immunotherapy : CII</searchLink> [Cancer Immunol Immunother] 2021 Nov; Vol. 70 (11), pp. 3277-3289. <i>Date of Electronic Publication: </i>2021 Apr 10. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Verlag%22">Springer Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>8605732 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-0851 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203407004%22">03407004 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Immunol Immunother <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33837851 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s00262-021-02924-5 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 3277 Titles: – TitleFull: Diacylglycerol kinase α inhibition cooperates with PD-1-targeted therapies to restore the T cell activation program. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Arranz-Nicolás J – PersonEntity: Name: NameFull: Martin-Salgado M – PersonEntity: Name: NameFull: Adán-Barrientos I – PersonEntity: Name: NameFull: Liébana R – PersonEntity: Name: NameFull: Del Carmen Moreno-Ortíz M – PersonEntity: Name: NameFull: Leitner J – PersonEntity: Name: NameFull: Steinberger P – PersonEntity: Name: NameFull: Ávila-Flores A – PersonEntity: Name: NameFull: Merida I IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 11 Text: 2021 Nov Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 1432-0851 Numbering: – Type: volume Value: 70 – Type: issue Value: 11 Titles: – TitleFull: Cancer immunology, immunotherapy : CII Type: main |
| ResultId | 1 |